| Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder S Goodwani, H Saternos, F Alasmari, Y Sari Neuroscience & Biobehavioral Reviews 77, 14-31, 2017 | 100 | 2017 |
| Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence F Alasmari, S Goodwani, RE McCullumsmith, Y Sari Progress in neurobiology 171, 32-49, 2018 | 83 | 2018 |
| Effects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol PSS Rao, H Saternos, S Goodwani, Y Sari Psychopharmacology 232, 2333-2342, 2015 | 65 | 2015 |
| Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats PSS Rao, S Goodwani, RL Bell, Y Wei, SHS Boddu, Y Sari Neuroscience 295, 164-174, 2015 | 62 | 2015 |
| Amoxicillin and amoxicillin/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions S Goodwani, PSS Rao, RL Bell, Y Sari Brain research 1622, 397-408, 2015 | 53 | 2015 |
| Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments J Ma, S Goodwani, PJ Acton, V Buggia-Prevot, SR Kesler, I Jamal, ... Pain 162 (10), 2599-2612, 2021 | 18 | 2021 |
| Discovery of IACS-52825, a potent and selective DLK inhibitor for treatment of chemotherapy-induced peripheral neuropathy K Le, MJ Soth, JB Cross, G Liu, WJ Ray, J Ma, SG Goodwani, PJ Acton, ... Journal of Medicinal Chemistry 66 (14), 9954-9971, 2023 | 14 | 2023 |
| Dual leucine zipper kinase is constitutively active in the adult mouse brain and has both stress-induced and homeostatic functions S Goodwani, C Fernandez, PJ Acton, V Buggia-Prevot, ML McReynolds, ... International journal of molecular sciences 21 (14), 4849, 2020 | 10 | 2020 |
| Basic Science and Pathogenesis J Ma, S Goodwani, M McReynolds, CH Huichalaf, V Buggia-Prevot, ... Alzheimer's and Dementia 20, e087772, 2024 | | 2024 |
| Targeting HDAC6 for chemotherapy‐induced neurotoxicity and Alzheimer’s disease J Ma, S Goodwani, M McReynolds, CH Huichalaf, V Buggia‐Prevot, ... Alzheimer's & Dementia 20, e087772, 2024 | | 2024 |
| RIP Kinase 1 (RIPK1) modulates disease associated microglial response during demyelination S Goodwani, YL Lightfoot, BG Ford, O Calderon, M McReynolds, K Allton, ... Alzheimer's & Dementia 19, e077538, 2023 | | 2023 |
| Exploring in vivo neural imaging as a readout for HDAC6 rescue of axonal transport after oxaliplatin-induced peripheral neuropathy L Le Roux, C Huichalaf, S Goodwani, M McReynolds, P Acton, J Ray, ... JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 26 (3), 412-412, 2021 | | 2021 |
| P4‐690: RIP KINASE 1 (RIPK1) MODULATES SELECTIVE PATHWAYS UNDERLYING THE MICROGLIAL RESPONSE TO A BROAD RANGE OF INFLAMMATORY AND NEURODEGENERATIVE STIMULI WITHOUT ELICITING … S Goodwani, YL Lightfoot, P Acton, JP Bardenhagen, V Buggia-Prevot, ... Alzheimer's & Dementia 15, P1596-P1596, 2019 | | 2019 |
| Homeostatic versus pathological functions of Dual Leucine Zipper Kinase in the adult mouse brain S Goodwani, ME Hamby, V Buggia-Prevot, P Acton, C Fernandez, ... bioRxiv, 479378, 2018 | | 2018 |
| P3‐058: CONSTITUTIVELY ACTIVE DUAL LEUCINE ZIPPER KINASE (DLK) REGULATES SYNAPTIC MAINTENANCE IN UNINJURED MOUSE CEREBELLUM S Goodwani, P Acton, V Buggia-Prevot, C Chakraborty, C Fernandez, ... Alzheimer's & Dementia 14 (7S_Part_20), P1087-P1087, 2018 | | 2018 |
| P2‐167: EXPRESSION OF THE DUAL LEUCINE ZIPPER KINASE IN DYSTROPHIC NEURITES AND AXONAL BEADING DURING PATHOLOGY PROGRESSION IN ALZHEIMER'S DISEASE V Buggia-Prevot, S Goodwani, C Fernandez, P Acton, RJ Vassar, WJ Ray Alzheimer's & Dementia 14 (7S_Part_13), P732-P732, 2018 | | 2018 |
| Dual Leucine Zipper Kinase (DLK) Constitutively Signals in the Uninjured Mouse Cerebellum S Goodwani, P Acton, V Buggia‐Prevot, C Chakraborty, M Hamby, ... The FASEB Journal 32, 687.11-687.11, 2018 | | 2018 |
| P2‐112: Expression of the Stress Response Regulatory Protein Dual Leucine Zipper Kinase (DLK) During the Development of Neuropathology in Alzheimer’s Disease V Buggia-Prevot, S Goodwani, C Chakraborty, R Shin, P Acton, W Ray Alzheimer's & Dementia 12, P655-P655, 2016 | | 2016 |
| P4‐023: Increasing the Expression of the Neuronal Survival Factor NMNAT2 with Small Molecule Modulators S Sanyal, B Roth, S Goodwani, G Smith, R Williams, W Stebbeds, MG Do, ... Alzheimer's & Dementia 12, P1023-P1024, 2016 | | 2016 |
| RIP Kinase 1 (RIPK1) mediates the disease associated microglial (DAM) phenotype in response to rapid demyelination induced by cuprizone but not by pathological tau in mouse models. S Goodwani, P Acton, K Allton, M McReynolds, YL Lightfoot, J Ma, CH Hu, ... 2021 Alzheimer's Association International Conference, 0 | | |
